中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Rare variants in the germline genome holistically determine receptor-independent Her2 signaling pathway activation and immune suppression, shaping pathological type and risk of HER2-negative breast cancer

文献类型:期刊论文

作者Yang, Mei1; Fan, Yanhui2; Wu, Zhi-Yong3; Feng, Zhendong2; Zhang, Qiangzu2; Han, Shunhua2; Zhang, Zhonghai5; Li, Xu5; Xue, Yiqing2; Li, Xiaoling1
刊名CANCER RESEARCH
出版日期2021-02-01
卷号81期号:4页码:1
ISSN号0008-5472
WOS研究方向Oncology
语种英语
WOS记录号WOS:000618737701207
出版者AMER ASSOC CANCER RESEARCH
源URL[http://119.78.100.204/handle/2XEOYT63/16896]  
专题中国科学院计算技术研究所期刊论文_英文
作者单位1.Guangdong Prov Peoples Hosp, Guangzhou, Guangdong, Peoples R China
2.Phil Rivers Technol, Beijing, Peoples R China
3.Sun Yat Sen Univ, Shantou Affiliated Hosp, Shantou, Peoples R China
4.Tsinghua Univ, Sch Med, Beijing, Peoples R China
5.Chinese Acad Sci, Inst Comp Technol, Beijing, Peoples R China
6.Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China
推荐引用方式
GB/T 7714
Yang, Mei,Fan, Yanhui,Wu, Zhi-Yong,et al. Rare variants in the germline genome holistically determine receptor-independent Her2 signaling pathway activation and immune suppression, shaping pathological type and risk of HER2-negative breast cancer[J]. CANCER RESEARCH,2021,81(4):1.
APA Yang, Mei.,Fan, Yanhui.,Wu, Zhi-Yong.,Feng, Zhendong.,Zhang, Qiangzu.,...&Wang, Kun.(2021).Rare variants in the germline genome holistically determine receptor-independent Her2 signaling pathway activation and immune suppression, shaping pathological type and risk of HER2-negative breast cancer.CANCER RESEARCH,81(4),1.
MLA Yang, Mei,et al."Rare variants in the germline genome holistically determine receptor-independent Her2 signaling pathway activation and immune suppression, shaping pathological type and risk of HER2-negative breast cancer".CANCER RESEARCH 81.4(2021):1.

入库方式: OAI收割

来源:计算技术研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。